Mpox (Human Monkeypox Virus) | Vermont Department of Health

Mpox (Human Monkeypox Virus) | Vermont Department of Health
CLOSE
Translations for you
Mpox (Human Monkeypox Virus)
Sexual Health and Sexually Transmitted Infections
Data Reports
Free Condoms
HIV Treatment and Care
Information for Health Care Providers
Prevention and Testing
Mpox (Human Monkeypox Virus)
Mpox—previously referred to as monkeypox or hMPXV— continues to circulate in the U.S.
Take steps to
prevent getting mpox
, including getting vaccinated if you're at risk.
There are two kinds of mpox, clade I and clade II.  Clade I usually causes more people with mpox to get severely sick or die compared to clade II. Mpox clade II continues to spread in many countries around the world, including the U.S. Mpox clade I is currently spreading mainly in certain countries in Africa.
Mpox is a viral illness that is mainly spread through close, personal (skin-to-skin) contact with someone who is infected. The most common symptom is a rash, which may look like pimples, blisters, or sores, or other more common rashes such as chicken pox, syphilis, or shingles. The rash can be extremely painful and leave scars. Other symptoms may include fever, headache, muscle aches, backaches, swollen lymph nodes, chills, and exhaustion.
Talk to your health care provider if you have a rash or other symptoms of mpox—even if you have been vaccinated or had mpox before. If you do not have a health care provider, call 2-1-1 to be connected to care, or contact the nearest
federally qualified health center
or one of
Vermont's Free & Referral Clinics
Learn more about mpox (CDC)
Find translated videos and factsheets in: American Sign Language / العربية / Arabic
မြန်မာစာ / Burmese
دری / Dari
Français / French
Kirundi
Maay Maay
Mandarin Chinese
नेपाली / Nepali
پښتو / Pashto
Soomaali / Somali
Español / Spanish
Swahili
українська / Ukrainian
Tiếng Việt / Vietnamese
Important Links
Info for Vermont Clinicians
Vaccine Eligibility, Locations and Information
Communication Materials and Resources
Mpox Testing Instructions for Clinicians
Mpox Information and Resources (CDC)
Traveling outside the U.S.?
Check the CDC's Travel Health Notices for potential global health risks related to outbreaks of mpox.
Travel Notices
Vaccines
Vaccination is an important tool against mpox. Vaccines make it less likely you will get or spread mpox. Although no vaccine is 100% effective, getting vaccinated may help make the symptoms less severe, easier to manage, and prevent serious illness, hospitalization, and death if you become infected. People who are vaccinated
should continue to avoid close, skin-to-skin contact
with someone who has mpox.
Who is Eligible in Vermont
Vaccination is FREE and available regardless of sexual orientation, gender identity or immigration status.
The following people can get vaccinated against mpox in Vermont:
People who
have or may have multiple or anonymous sex partners
, or participate or may participate in group sex.
People
whose sex partners are eligible
per the criteria above.
People who
know or suspect they have been exposed
to mpox in the last 14 days.
Anyone else who considers themselves to be
at risk for mpox
through sex or other intimate contact.
Certain health care and laboratory personnel whose
jobs regularly put them at high risk of exposure
to the virus, such as performing testing or caring for multiple people infected with mpox.
Who is Recommended for Vaccination
In addition to the above vaccine eligibility criteria, the CDC recommends vaccines for those at higher risk of coming into contact with someone infected with mpox.
This includes if:
You are a gay, bisexual, or other man who has sex with men or a transgender, nonbinary, or gender-diverse person who in the past 6 months has a new diagnosis of one or more sexually transmitted diseases (e.g., chlamydia, gonorrhea, or syphilis) or more than one sex partner.
In the past 6 months you have had sex at a commercial sex venue (like a sex club or bathhouse), sex related to a large commercial event or in a geographic area (city or county for example) where mpox virus transmission is occurring, or sex in exchange for money or other items.
You have HIV or other causes of immune suppression and have had recent or anticipate future risk of mpox exposure.
More on CDC vaccination recommendations
How to Get Vaccinated
Mpox vaccine (named JYNNEOS) can be given by appointment at many primary care practices, pharmacies, and
local health offices
. Find other vaccine locations near you with the vaccine locator tool below. Please check with the location when you make your appointment to confirm they have mpox vaccines.
Anyone recommended to get the vaccine can get vaccinated in Vermont if they live, work, receive primary care, or are spending an extended period in Vermont. This includes non-U.S. citizens and individuals without insurance.
Mpox vaccines are available at no cost to you.
Individuals under 65 years can get the vaccine at no cost at most health care provider offices in Vermont.
For most people, their health insurance will cover the cost of getting vaccinated.
Health care providers can charge a small fee to give the vaccine.
Talk to your doctor before getting vaccinated to find out how much it may cost. Some practices offer a sliding scale.
If you are under 65 and do not have a primary care provider or are unable to pay an administrative fee to get vaccinated, you can make an appointment at your
local health office
. Local health offices do not charge a fee for giving the vaccine.
About the Vaccine
The JYNNEOS vaccine helps protect against mpox when given before or shortly after having close, personal contact with someone who is infected. The vaccine is two doses, given four weeks apart.
It is recommended to get both doses for stronger protection against mpox. You can still get your second dose even if it has been more than four weeks since your first dose. Protection is highest two weeks after your second dose. No vaccine is 100% effective, and infections after vaccination are possible, but they may be milder and less likely to result in hospitalization. The CDC is still learning how long JYNNEOS vaccine protection lasts and if protection decreases over time.
Possible Vaccine Side Effects
Not everyone has side effects, but some people do. It is important to weigh possible side effects from the vaccine with the symptoms of a mpox infection, which could be painful and serious, and result in permanent scarring from the rash.
The most common side effects from JYNNEOS are pain, redness, and itching at the spot where the vaccine is given. You might also experience fever, headache, tiredness, nausea, chills, and muscle aches.
Visit the CDC's website for more on vaccines for mpox
Treatment
Treatment is available if you are diagnosed with mpox and your health care provider determines that you need it. If you do not have a health care provider, call 2-1-1 to be connected to care, or contact the nearest
federally qualified health center
or one of
Vermont's Free & Referral Clinics
Communication Materials and Resources
Find our Mpox Partner Toolkit, printable poster, fact sheets and videos in translated into multiple languages.
Get social media content and other communication resources from the CDC
Print Materials
Partner Toolkit (Rev. 6/30/2023)
Vaccine Poster 8.5x11
Printable Poster 8.5"x11"
Fact Sheet (English)
Fact Sheet (العربية / Arabic)
Fact Sheet ( မြန်မာစာ / Burmese)
Fact Sheet (Chinese Cantonese)
Fact Sheet (Chinese Mandarin)
Fact Sheet ( دری / Dari)
Fact Sheet (Français / French)
Fact Sheet (Kirundi)
Fact Sheet (नेपाली / Nepali)
Fact Sheet (پښتو / Pashto)
Fact Sheet (Soomaali / Somali)
Fact Sheet (Español / Spanish)
Fact Sheet (Swahili)
Fact Sheet (українська / Ukrainian)
Fact Sheet (Tiếng Việt / Vietnamese)
Videos in Multiple Languages
"How Mpox Spreads and Symptoms" from Vermont Language Justice Project.
American Sign Language
العربية / Arabic
မြန်မာစာ / Burmese
دری / Dari
Français / French
Kirundi
Maay Maay
Mandarin Chinese
नेपाली / Nepali
پښتو / Pashto
Soomaali / Somali
Español / Spanish
Swahili
українська / Ukrainian
Tiếng Việt / Vietnamese
Mpox Information for Clinicians
Patients eligible for
vaccination
may contact your office looking for this vaccine. If you have a patient who meets
eligibility requirements
, please contact the Health Department at
[email protected]
. You will be referred to an administering location or instructed on how to obtain a dose for your patient.
What To Do if Clinicians Suspect Mpox?
Clinicians who suspect mpox should call the Infectious Disease Program at (802) 863-7240, Option 2 to speak with an epidemiologist 24/7.
Follow appropriate
isolation and infection control protocols
An epidemiologist will guide you through the process of specimen collection and sending specimens to the Vermont Department of Health Laboratory (VDHL). Testing is also available through commercial labs Labcorp, Aegis, Quest, and Mayo. Turn-around time and cost may vary by lab.
Clinicians who see a patient with a rash characteristic of mpox and one or more risk factors—regardless of vaccination status— should have a low threshold for testing for mpox. Other more common diseases (e.g., HSV, VZV) can be simultaneously ruled in or out through usual diagnostic channels. Find
more information on mpox
for health care professionals at the CDC.
How to Collect and Send a Specimen for Mpox Testing
Locate collection materials
Pre-made kits are available by request.
Call the Vermont Department of Health Laboratory at 802-338-4724 (available M-F, 7:45am - 4:30pm).
If you don’t have access to a kit, you may be able to assemble your own. You’ll need:
Two dry nylon flocked swabs (Copan P/N 502cs01)
Two sterile viral transport media tubes containing at least 1mL of VTM
Labels for specimen tubes and cooler
Two biohazard bags
Two
Clinical Laboratory Test Request forms
, one per sample
One cooler
Cold packs
Collect the specimens
Read through the directions entirely before proceeding.
We recommend labeling your tubes before you begin specimen collection so swabs can go directly into pre-labeled tubes.
Select two lesions
, preferably from different locations on the body and with different appearances
Vigorously swab or brush
each lesion
with a different sterile dry nylon swab. Rub as vigorously as the patient can tolerate to ensure a conclusive result.
Insert each swab into a VTM tube. Label each tube indicating patient name, date of birth. lesion location, and collection date and time then place in a biohazard bag.
Specimens can be stored for up to two days at 15-30°C (room temperature) or up to seven days at 2-8°C (refrigerated). Temperature timelines need to be considered for shipping. Please do not ship room temperature specimens that have already been stored for two days. Refrigerated specimens should be sent in a cooler with cold packs to maintain temperature.
Specimens must arrive at the Lab within seven days of collection.
Package the specimens
Complete a
Clinical Laboratory Test Request Form
for
each site.
Include the site of the lesion on the request form. Select “MPOX PCR” in the Molecular Virology section. See
an example of a completed form here.
Specimens should be packaged and transported as Category B specimens as outlined in
Transporting Infectious Substances Safely
Segregate tubes by site of lesion then, in each biohazard bag, include the request form in the outer pocket (not in the pocket with the specimen).
For example:
if you chose an elbow and a knee lesion, you should have two bags, one with a tube labeled “elbow” and one with a tube labeled “knee” each with their own request form in the outer pocket of the bag.
Place the specimen bags with the request forms in a cooler with a frozen ice pack.
Send the specimens
Seal the cooler and address the label to: VDHL, 359 South Park Dr, Colchester, VT 05446.
Fill out the “Person Responsible (Name and Phone number)” label with someone who can answer questions about the package.
If using an assembled kit, add a UN 3373 Biological Substance, Category B label to comply with DOT/IATA shipping regulations. Mark “MPOX PCR” on the outside of the package. Pre-made kits will include this label.
Please do not send specimens to the Lab without prior approval.
After your initial conversation with Epidemiology, Lab staff will reach out to discuss the best means of specimen transport.
Receive Results
Someone from Epidemiology will verbally notify you of a positive result.
An official lab report will follow based on contact information provided on the
Clinical Laboratory Test Request Form
Providers will share the results with their patients.
Download Specimen Collection and Submission Instructions
Resources for Clinicians
Mpox Partner Toolkit
Vermont Health Alert Network
CDC Info for Health Care Professionals
CDC Health Alert Network
COCA Calls and Webinars (CDC)
CDC/ISDA Clinician Calls (Infectious Diseases Society of America)
JYNNEOS Immunization Guidance
Topics:
Infectious Diseases
Resources for Health Professionals
Resources for Physician Assistants
Resources for Physicians
March 23, 2026